Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 184

The DOI matches its Crossref record.

Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

Dhib-Jalbut, Suhayl·2002·Neurology

Abstract

MS is an immunologically mediated disease, as determined by observation of the response to immunotherapy and the existence of an animal model, experimental autoimmune encephalitis. Interferon (IFN) beta-1b, IFN beta-1a, and glatiramer acetate, the therapies used for relapsing or remitting MS, have mechanisms of action that address the immunologic pathophysiology of MS. The IFNs bind to cell surface-specific receptors, initiating a cascade of signaling pathways that end with the secretion of antiviral, antiproliferative, and immunomodulatory gene products. Glatiramer acetate, a synthetic molecule, inhibits the activation of myelin basic protein-reactive T cells and induces a T-cell repertoire characterized by anti-inflammatory effects. Although the two classes of drugs have some overlapping mechanisms of action, the IFNs rapidly block blood-brain barrier leakage and gadolinium (Gd) enhancement within 2 weeks, whereas glatiramer acetate produces less rapid resolution of Gd-enhanced MRI activity. IFN beta has no direct effects in the CNS, but glatiramer acetate-specific T cells are believed to have access to the CNS, where they can exert anti-inflammatory and possibly neuroprotective effects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.58.8_suppl_4.s3

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 58

  1. 10.1038/ni0901-785 · DOI
  2. 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q · DOI
  3. 10.1023/A:1012128406432 · DOI
  4. Allain H, Schuck S. Observations on differences between interferons used to treat multiple sclerosis. J Clin Res . 1998; 1: 381–392.
  5. 10.1212/WNL.46.6.1639 · DOI
  6. 10.1212/WNL.51.3.738 · doi:10.1212/wnl.51.3.738
  7. 10.2165/00044011-199918010-00004 · DOI
  8. 10.1212/WNL.56.2.148 · DOI
  9. 10.1212/WNL.53.4.679 · DOI · Paper page
  10. 10.1212/WNL.54.11.2055 · DOI
  11. 10.1177/135245859700300609 · DOI
  12. 10.1212/WNL.51.3.682 · DOI · Paper page
  13. 10.1056/NEJM200007133430207 · DOI · Paper page
  14. 10.1212/WNL.37.7.1097 · DOI · Paper page
  15. 10.1016/0165-5728(95)00072-A · DOI
  16. 10.1172/JCI119455 · DOI · Paper page
  17. 10.1046/j.1365-3083.2000.00688.x · DOI
  18. 10.1016/S0165-5728(98)00271-9 · DOI
  19. 10.4049/jimmunol.165.1.548 · DOI
  20. 10.1002/ana.1096 · DOI · Paper page
  21. 10.1212/WNL.48.5.1446 · DOI
  22. 10.1016/S0165-5728(96)00156-7 · DOI
  23. 10.1002/ana.410410517 · DOI
  24. 10.1016/0165-5728(95)00054-6 · DOI
  25. 10.1093/brain/122.7.1261 · DOI
  26. 10.1212/WNL.53.7.1397 · DOI · Paper page
  27. 10.1002/ana.410400607 · DOI · Paper page
  28. 10.1002/ana.410400606 · DOI · Paper page
  29. 10.1212/WNL.53.7.1380 · DOI
  30. 10.1016/0165-5728(91)90054-B · doi:10.1016/0165-5728(91)90054-b
  31. 10.1016/S0165-5728(97)00034-9 · DOI · Paper page
  32. 10.1177/135245859600200403 · doi:10.1177/135245859600200403
  33. 10.1126/science.279.5355.1344 · DOI · Paper page
  34. 10.1073/pnas.92.16.7440 · DOI · Paper page
  35. 10.1212/WNL.56.1.74 · DOI
  36. 10.1016/S0065-2776(08)60273-4 · DOI · Paper page
  37. 10.1016/0165-2478(96)02506-0 · DOI
  38. 10.1002/eji.1830010406 · DOI · Paper page
  39. 10.1056/NEJM198708133170703 · DOI · Paper page
  40. 10.1212/WNL.45.7.1268 · DOI · Paper page
  41. 10.1212/WNL.56.6.702 · DOI · Paper page
  42. 10.1212/WNL.55.11.1704 · DOI · Paper page
  43. 10.1073/pnas.96.2.634 · DOI · Paper page
  44. 10.1073/pnas.97.21.11472 · DOI · Paper page
  45. 10.1146/annurev.immunol.15.1.297 · DOI · Paper page
  46. 10.1177/135245850100700401 · DOI
  47. 10.1073/pnas.97.13.7446 · DOI · Paper page
  48. 10.1212/WNL.57.4.731 · DOI · Paper page
  49. 10.1002/ana.64 · DOI · Paper page
  50. 10.1212/WNL.50.3.701 · DOI · Paper page
  51. 10.1016/S0165-5728(98)00191-X · DOI · Paper page
  52. 10.1016/0165-5728(95)00085-G · doi:10.1016/0165-5728(95)00085-g
  53. 10.1002/1531-8249(200001)47:1<127::AID-ANA22>3.0.CO;2-1 · doi:10.1002/1531-8249(200001)47:1<127::aid-ana22>3.0.co;2-1
  54. 10.1212/WNL.56.2.148 · DOI
  55. Dhib-Jalbut S, Chen M, Costello K, Panitch H. Effect of combined IFN beta-1a and glatiramer acetate (GA) therapy on GA-T-cell responses in MS. Neurology . 2001; 56 (suppl 3): A225.Abstract.
  56. 10.1002/jnr.490280213 · DOI · Paper page
  57. Antel JP, Biernacki K, Prat A. Migratory behavior of Th1 and Th2 T cells across human brain-derived endothelial cells. Neurology . 2000; 54 (suppl 3): A149.Abstract.
  58. 10.1126/science.7680493 · DOI · Paper page

Cited by

See all 184

Metadata

Authors
Dhib-Jalbut, S.
Venue
Neurology
Published
2002-04-23
Volume
58
Issue
8_suppl_4
Pages
S3-9
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2111468824
Cited by
184
References
0
FWCI
7.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis. https://app.cochat.ai/papers/10.1212/wnl.58.8_suppl_4.s3
The paper
Dhib-Jalbut, S. (2002). Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis. Neurology. https://doi.org/10.1212/wnl.58.8_suppl_4.s3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.